Splash Beverage Group, Inc. (NYSE: SBEVW)

Splash Beverage Group, Inc. is a portfolio company that historically managed brands within the consumer beverage industry. The company currently focuses on the development and distribution of its Chispo Tequila brand while pursuing a potential acquisition of Medterra CBD a manufacturer of federally compliant cannabinoid wellness products. Its core activities involve sourcing producing and marketing beverage alcohol products and evaluating expansion into the wellness sector.

The company generates revenue primarily from the sale of Chispo Tequila through independent distributors and on premise hospitality accounts such as Senor Frog s. Revenue is recognized when product is shipped to distributors who then sell to retail and venue locations. In addition the company anticipates future revenue from the sale of cannabinoid wellness products contingent upon the completion of the Medterra acquisition. Historically revenue has been limited due to insufficient capital resources which prevented operations from February 2025 through March 2026.

The beverage alcohol industry is highly competitive with numerous international national regional and local producers and distributors. Competitive success depends on price promotional activity advertising marketing programs point of sale merchandising retail space management customer service product differentiation packaging innovation and distribution methods. Splash Beverage Group Inc seeks to differentiate its Chispo Tequila through an authentic blue agave blanco profile and its placement as the house tequila for Senor Frog s locations. If the Medterra acquisition is completed the company expects to gain a position in the growing cannabinoid wellness market where competition includes established CBD and hemp derived product makers.

The company serves on premise hospitality channels including restaurants bars and hotels with Senor Frog s being a named house tequila partner across locations in Florida the Bahamas and Mexico. It also supplies independent distributors who place the product in retail stores in the United States Guatemala and Europe. Should the Medterra transaction close the customer base would expand to include consumers of cannabinoid wellness products sold through wellness retailers and online channels.